← Leaderboards
Andrea Grace Hohmann
University Of Georgia (Uga)
$10,920,578
Attributed
$16,340,359
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,340,359 · 19
By mechanism
R01$9,302,931 · 6
R44$1,979,001 · 1
T32$1,264,361 · 1
R21$1,128,604 · 3
RC1$892,446 · 1
P01$844,565 · 2
Top collaborators
- Kenneth P. Mackie16 shared
- Michael Courtney5 shared
- George V Rebec2 shared
- Lauren Jennifer Schwimmer2 shared
- Gustavo Pesce1 shared
- Patrick Donovan Quinn1 shared
- Toshihiko Takeuchi1 shared
- Ganesh A Thakur1 shared
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainCannabinoidsSignal TransductionMediatingAgonistCellsNociceptionDoseAnalgesicsCannabinoid ReceptorPainful NeuropathyReceptor SignalingNeuronsInnovationBaseTreatment EfficacyIn VitroOpioidNeuropathyCnr2 GeneBindingIn VivoLigandsEndocannabinoids
Grant awards (54)
Development of non-opioid, non-addictive analgesics for treating neuropathic pain$675,107
R01 · FY2025 · NS
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$216,204
T32 · FY2025 · DA
Project 3 - In vivo pharmacology of cannabinoid receptor probes$209,673
P01 · FY2025 · DA · contact PI
A peripherally restricted MOR agonist for effective pain management with reduced risks$399,230
R43 · FY2024 · DA
Project 3 - In vivo pharmacology of cannabinoid receptor probes$213,275
P01 · FY2024 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$163,780
T32 · FY2024 · DA
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2023 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$231,250
T32 · FY2023 · DA
Project 3 - In vivo pharmacology of cannabinoid receptor probes$209,355
P01 · FY2023 · DA · contact PI
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$1,063,128
R44 · FY2022 · CA
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2022 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$227,181
T32 · FY2022 · DA
Project 3 - In vivo pharmacology of cannabinoid receptor probes$212,262
P01 · FY2022 · DA · contact PI
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$915,873
R44 · FY2021 · CA
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2021 · DA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$214,088
T32 · FY2021 · DA
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2020 · DA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2020 · DA · contact PI
NOS1AP as a novel target for treating pathological pain$282,800
R01 · FY2020 · CA · contact PI
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY$211,858
T32 · FY2020 · DA
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence$517,184
R01 · FY2019 · DA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2019 · DA · contact PI
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain$299,999
R43 · FY2019 · CA
NOS1AP as a novel target for treating pathological pain$274,315
R01 · FY2019 · CA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2018 · DA · contact PI
NOS1AP as a novel target for treating pathological pain$282,800
R01 · FY2018 · CA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2017 · DA · contact PI
NOS1AP as a novel target for treating pathological pain$281,910
R01 · FY2017 · CA · contact PI
A Novel Mechanism for Decreasing Opioid Reward$196,875
R21 · FY2017 · DA · contact PI
Role of CB2 in Analgesic Mechanisms$351,000
R01 · FY2016 · DA · contact PI
NOS1AP as a novel target for treating pathological pain$295,021
R01 · FY2016 · CA · contact PI
A Novel Mechanism for Decreasing Opioid Reward$195,156
R21 · FY2016 · DA · contact PI
Protein-protein interaction inhibitors as novel analgesics$234,000
R21 · FY2014 · DA · contact PI
Protein-protein interaction inhibitors as novel analgesics$195,000
R21 · FY2013 · DA · contact PI
2013 Cannabinoid Function in the CNS Gordon Research Conference & Gordon Research$40,365
R13 · FY2013 · DA · contact PI
2011 Gordon Research Seminar on Cannabinoid Function in The CNS$15,000
R13 · FY2011 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$497,570
R01 · FY2010 · DA · contact PI
An Animal Model of Therapeutic Self-Medication for Neuropathic Pain$396,378
RC1 · FY2010 · DA · contact PI
An Animal Model of Therapeutic Self-Medication for Neuropathic Pain$496,068
RC1 · FY2009 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$490,049
R01 · FY2009 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$11,984
R01 · FY2009 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$441,672
R01 · FY2008 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$428,315
R01 · FY2007 · DA · contact PI
ENDOCANNABINOID ANALGESIA: AN IN VIVO GENE TRANSFER - LIPIDOMICS APPROACH$145,711
R21 · FY2007 · DA · contact PI
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA$446,634
R01 · FY2006 · DA · contact PI
ENDOCANNABINOID ANALGESIA: AN IN VIVO GENE TRANSFER - LIPIDOMICS APPROACH$161,862
R21 · FY2006 · DA · contact PI
PERIPHERAL CANNABINOID MODULATION OF PAIN TRANSMISSION$9,936
R01 · FY2005 · DA
PERIPHERAL CANNABINOID MODULATION OF PAIN TRANSMISSION$177,721
R01 · FY2004 · DA
PERIPHERAL CANNABINOID MODULATION OF PAIN TRANSMISSION$139,570
R01 · FY2003 · DA
PERIPHERAL CANNABINOID MODULATION OF PAIN TRANSMISSION$32,035
R01 · FY2003 · DA
PERIPHERAL CANNABINOID MODULATION OF PAIN TRANSMISSION$194,572
R01 · FY2002 · DA
ENDOCANNABINOID MECHANISMS OF STRESS INDUCED ANALGESIA$72,400
R03 · FY2002 · DA
ENDOCANNABINOID MECHANISMS OF STRESS INDUCED ANALGESIA$29,057
R03 · FY2002 · DA
ENDOCANNABINOID MECHANISMS OF STRESS INDUCED ANALGESIA$72,400
R03 · FY2001 · DA